[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369849-105":59,"doc-detail-369849-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","hiv-1-viremia-and-cancer-risk-in-28-million-people-the-south-african-hiv-cancer-match-study","HIV-1 Viremia and Cancer Risk in 2.8 Million People - The South African HIV Cancer Match Study","","HIV-1 viremia and cancer risk have been studied mainly in high-income settings, leaving uncertainty for people with HIV (PWH) in sub-Saharan Africa. This study evaluates the association between time-updated HIV-1 RNA viral load and incidence of multiple cancer types among PWH in South Africa. Data from 2004–2014 combined laboratory results and cancer registry records, analyzed using Cox models. After adjustment for CD4 count, higher HIV-1 viremia increased risks of Kaposi sarcoma, leukemia, non-Hodgkin lymphoma, conjunctival cancer, and colorectal cancer, supporting the need for sustained viral suppression to prevent cancer.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hiv-1-viremia-and-cancer-risk-in-28-million-people-the-south-african-hiv-cancer-match-study/369849/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hiv-1-viremia-and-cancer-risk-in-28-million-people-the-south-african-hiv-cancer-match-study/369849.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about HIV-1 viremia and cancer risk?","Question",{"text":112,"@type":113},"It evaluates the association between HIV-1 viremia and the risk of various cancer types among people with HIV in South Africa.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data sources and time period were used in the analysis?",{"text":117,"@type":113},"The study used laboratory measurements from the National Health Laboratory Service and cancer records from the National Cancer Registry for the years 2004 to 2014.",{"name":119,"@type":110,"acceptedAnswer":120},"Which cancers showed increased risk in the fully adjusted model?",{"text":121,"@type":113},"In the fully adjusted model, HIV-1 viremia was associated with increased risk of Kaposi sarcoma, leukemia, non-Hodgkin lymphoma, conjunctival cancer, and colorectal cancer.",{"name":123,"@type":110,"acceptedAnswer":124},"What is the main conclusion regarding prevention?",{"text":125,"@type":113},"The findings emphasize the importance of sustained viral suppression for cancer prevention among people with HIV in South Africa.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},369849,1790218000,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Clinical Infectious Diseases  \nMAJOR ARTICLE  \nHIV-1 Viremia and Cancer Risk in 2.8 Million People: The South African HIV Cancer Match Study  \nYann Ruffieux,1, Judith Mwansa-Kambafwile,2,3 Carole Metekoua,1,2,4, Tinashe Tombe-Nyahuma,2 Julia Bohlius,1,5,6, Mazvita Muchengeti,2,3,7, Matthias Egger,1,8,9, and Eliane Rohner1,  \n1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; 2National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa; 3School of Public Health, University of Witwatersrand, Johannesburg, South Africa; 4Graduate School for Health Sciences, University of Bern, Bern, Switzerland; 5Swiss Tropical and Public Health Institute, Allschwil, Switzerland; 6University of Basel, Basel, Switzerland; 7South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa; 8Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom; and 9Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health, University of Cape Town, Cape Town, South Africa  \nBackground. Most research on human immunodeficiency virus-1 (HIV-1) viremia and cancer risk is from high-income countries. We evaluated the association between HIV-1 viremia and the risk of various cancer types among people with HIV (PWH) in South Africa.  \nMethods. We analyzed data from the South African HIV Cancer Match study, based on laboratory measurements from the National Health Laboratory Service and cancer records from the National Cancer Registry from 2004 to 2014. Using Cox proportional hazards models, we estimated hazard ratios (HR) for cancer incidence per unit increase in time-updated Log10 HIV-1 RNA viral load copies/mL. We created partially adjusted (sex, age, calendar year) and fully adjusted models (additionally including time-updated CD4 count) .  \nResults. We included 2 770 200 PWH with 10 175 incident cancers; most common were cervical cancer (N = 2481), Kaposi sarcoma (N = 1902), breast cancer (N = 1063), and non-Hodgkin lymphoma (N = 863) . Hazard ratios for the association of HIV-1 viremia and cancer risk changed after partial and full adjustment and were generally attenuated for infection-related cancers but tended to increase for infection-unrelated cancers. In the fully adjusted model, HIV-1 viremia was associated with an increased risk of Kaposi sarcoma (HR per unit increase in Log10 HIV-1 RNA viral load: 1.38; 95% confidence interval [CI], 1.35–1.42), leukemia (HR: 1.28; 95% CI, 1.13–1.45), non-Hodgkin lymphoma (HR: 1.24; 95% CI, 1.19–1.29), conjunctival cancer (HR: 1.19; 95% CI, 1.11–1.25), and colorectal cancer (HR: 1.11; 95% CI, 1.02–1.21) . Associations with other cancer types were weaker or absent.  \nConclusions. Our findings underline the importance of sustained viral suppression for cancer prevention among PWH in South Africa.  \nKeywords. HIV-1 viremia; cancer; incidence; South Africa; linkage study.  \nIn 1996, the International Agency for Research on Cancer categorized human immunodeficiency virus-1 (HIV-1) as carcinogenic in humans [ 1] . HIV-1–induced cellular immunodeficiency with low CD4 cell counts is strongly associated with several infection-related and some infection-unrelated cancers among people with HIV (PWH) [2–4] . Furthermore, independently of immunodeficiency, HIV-1 replication may increase cancer risk through chronic inflammation, accelerated immunosenescence, and direct pro-oncogenic effects [5–7]. It is well  \nReceived 10 October 2024; editorial decision 19 December 2024; published online 30 December 2024  \nCorrespondence: E. Rohner, Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland ([eliane.rohner@unibe.ch](eliane.rohner@unibe.ch)) .  \nClinical Infectious Diseases® 2025;81(2):286–95  \n© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Dis","cbCaiqfMBEZbnwaj","https://ap.wps.com/l/cbCaiqfMBEZbnwaj","pdf",814510,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Context and Rationale","[{\"question\":\"What question does the study address about HIV-1 viremia and cancer risk?\",\"answer\":\"It evaluates the association between HIV-1 viremia and the risk of various cancer types among people with HIV in South Africa.\"},{\"question\":\"What data sources and time period were used in the analysis?\",\"answer\":\"The study used laboratory measurements from the National Health Laboratory Service and cancer records from the National Cancer Registry for the years 2004 to 2014.\"},{\"question\":\"Which cancers showed increased risk in the fully adjusted model?\",\"answer\":\"In the fully adjusted model, HIV-1 viremia was associated with increased risk of Kaposi sarcoma, leukemia, non-Hodgkin lymphoma, conjunctival cancer, and colorectal cancer.\"},{\"question\":\"What is the main conclusion regarding prevention?\",\"answer\":\"The findings emphasize the importance of sustained viral suppression for cancer prevention among people with HIV in South Africa.\"}]","HIV-1 Viremia and Cancer Risk in 2.8 Million People - The South African HIV Cancer Match Study | PDF",1790184855,25,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c8439cb018e4fcf1d4f411a2f877cd6.webp",983,1296,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0598cb054c87e8acd3d7d0bbae94ed3b.webp",982,1294,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1197ed44731a52ad532c26fabec7151.webp",981,1293,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1342b1cf2c8cfbb44fe63fae0d19b033.webp",980,1292]